Development of an HTRF Assay for the Detection and Characterization of Inhibitors of Catechol-O-Methyltransferase

Mannisto, 1999, Catechol-O-Methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors, Pharmacol. Rev., 51, 593 Lotta, 1995, Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase—A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme, Biochemistry, 34, 4202, 10.1021/bi00013a008 Bai, 2007, Biochemical and Molecular Modeling Studies of the O-Methylation of Various Endogenous and Exogenous Catechol Substrates Catalyzed by Recombinant Human Soluble and Membrane-Bound Catechol-O-Methyltransferases, Chem. Res. Toxicol., 20, 1409, 10.1021/tx700174w Barrow, 2012, Inhibitors of Catechol-O-Methyltransferase, CNS Neurol. Disord.-Drug. Tgt., 11, 324, 10.2174/187152712800672517 Learmonth, 2010, The Chemistry of Catechol O-Methyltransferase Inhibitors, Int. Rev. Neurobiol., 95, 119, 10.1016/B978-0-12-381326-8.00006-5 Nutt, 1984, Pharmacokinetics of Levodopa, Clin. Neuropharmacol., 7, 35, 10.1097/00002826-198403000-00002 Marsala, 2012, A Systematic Review of Catechol-O-Methyltransferase Inhibitors: Efficacy and Safety in Clinical Practice, Clin. Neuropharmacol., 35, 185, 10.1097/WNF.0b013e31825c034a Haasio, 2010, Toxicology and Safety of Comt Inhibitors, Int. Rev. Neurobiol., 95, 163, 10.1016/B978-0-12-381326-8.00007-7 Graves, 2008, A Universal Competitive Fluorescence Polarization Activity Assay for S-Adenosylmethionine Utilizing Methyltransferases, Anal. Biochem., 373, 296, 10.1016/j.ab.2007.09.025 Robinson, 2012, Characterization of Non-Nitrocatechol Pan and Isoform Specific Catechol-O-Methyltransferase Inhibitors and Substrates, ACS Chem. Neurosci., 3, 129, 10.1021/cn200109w Rivett, 1982, Kinetic-Studies on the O-Methylation of Dopamine by Human-Brain Membrane-Bound Catechol O-Methyltransferase, Biochemistry, 21, 1740, 10.1021/bi00537a006 Vieira-Coelho, 1999, Effects of Tolcapone upon Soluble and Membrane-Bound Brain and Liver Catechol-O-Methyltransferase, Brain Res., 821, 69, 10.1016/S0006-8993(99)01063-X Lautala, 2001, Molecular Mechanisms Controlling the Rate and Specificity of Catechol O-Methylation by Human Soluble Catechol O-Methyltransferase, Mol. Pharmacol., 59, 393, 10.1124/mol.59.2.393 Borges, 1997, Studies on the Tight-Binding Nature of Tolcapone Inhibition of Soluble and Membrane-Bound Rat Brain Catechol-O-Methyltransferase, J. Pharmacol. Exp. Ther., 282, 812 Almeida, 2013, Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects, Clin. Pharmacokinet., 52, 139, 10.1007/s40262-012-0024-7